SHARE

Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
09.03.2023

Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score

Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score

Porton Pharma Solutions Ltd. is proud to announce that it has made the top quartile of the S&P Corporate Sustainability Assessment for the first time. On February 28, S&P Global released a new set of S&P Global ESG Scores, where Porton Pharma scored 29 out of 100. The score is above the industry average and shows Porton’s commitment to sustainable development and integrating the ESG concept into its daily operations.

This achievement is attributed to Porton’s conscientious practices of corporate social responsibility and social welfare initiatives. Focusing on its customers, employees, shareholders, suppliers, environment, and communities, Porton has been striving to continuously enhance its policies and practices in corporate governance, compliance operation, and reliable delivery of products and services.

Porton Chief Executive Officer Oliver Ju is an active supporter and advocate of diversity. Since founding Porton, Oliver has spent extra effort creating a safe and inclusive work environment for people from different backgrounds. In addition to building a workplace where everyone is welcome, Porton seeks to contribute to green development and sustainability to foster an environment conducive to growth. During these trying times, Porton works hard to maintain a sustainable supply chain and integrate an EHS (Environment, Health, and Safety) policy into its corporate processes.

Before achieving this significant S&P Global ESG score, Porton had already been making an impact. Last year, it gained an AA score in CNI ESG ratings, an A+ in IIGH ESG ratings, and a BBB in MSCI ESG ratings. Porton also received multiple ESG awards, including the 2022 Top 100 ESG Chinese Listed Companies and the 2022 Top 10 Chinese Pharmaceutical Listed Companies with the Most ESG Investment Value.

While Porton continues to gain ground in its environmental, social, and governance initiatives, this is only the beginning. Embedded in its DNA is a corporate social responsibility to help clients develop high-impact and life-saving medicines in a sustainable and ethical manner. Given this, Porton is committed to enabling early access to good medicines, ensuring its employees’ health and wellbeing, and establishing transparency with its stakeholders.

SHARE

Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details